Healthcare Professionals
Advancing Wound Care Through Clinical Evidence & Real-World Success
BY DR. Vijay Viswanathan, MD, PhD
Recombinant Human Epidermal Growth Factor in Diabetic Foot Ulcers
- 78% Complete Healing in 30 Days (vs 52% Placebo)
- Faster Healing: 45 Days vs 72 Days (p < .0001)
- 3.6-Fold Increase in Collagen Formation
- Improved Granulation & Epithelialization
- Demonstrated Safety & Clinical Efficacy in RCT
(source : Viswanathan et al., Int J Low Extrem Wounds, 2019)
Real-Life Stories
45-Day Management of a Chronic Arterial Ulcer
A 53-year-old male presented with a chronic arterial ulcer measuring 6.2 cm × 4.8 cm with a depth of 0.8 cm. Baseline evaluation showed approximately 30% necrotic tissue, moderate exudate, inflamed wound margins, and a pain score of 7/10, consistent with delayed healing secondary to arterial insufficiency
Structured Clinical Management of Wet Gangrene: 42-Day Outcome
A 52-year-old male presented with wet gangrene of the great toe, characterized by extensive necrosis, erythema, edema, and foul discharge, consistent with infection and compromised perfusion. Baseline findings indicated advanced tissue necrosis requiring immediate structured intervention.
6-Week Treatment Outcome: Diabetic Foot Ulcer
A 48-year-old female presented with a diabetic foot ulcer requiring structured wound management. Baseline assessment indicated non-viable tissue necessitating immediate debridement